Target intelligence / Profile preview

Teichoic acid poly(glycerol phosphate) polymerase (TagF) (TagF)

Target
TagF
Molecular classification
Enzyme, Transferase
01

Overview

Teichoic acid poly(glycerol phosphate) polymerase, commonly known as TagF, is an essential bacterial enzyme responsible for the polymerization of the main chain of wall teichoic acids (WTAs) in many Gram-positive bacteria, including Staphylococcus aureus and Bacillus subtilis (UniProt P13485). It catalyzes the sequential transfer of glycerol phosphate units from CDP-glycerol to a membrane-anchored linkage unit, creating anionic polymers that are critical for cell division, morphology, and virulence (Fitzgerald & Foster, 2000, PubMed 10648531). Because WTAs are indispensable for the viability of many pathogenic species and the enzyme has no human homolog, TagF has emerged as a high-priority therapeutic target for developing novel antibacterial agents to combat drug-resistant infections (Sewell et al., 2009, PubMed 19411246). Structural studies have revealed that TagF is a monotopic membrane protein, allowing its active site to access lipid-bound substrates within the bacterial bilayer (Lovering et al., 2010, PubMed 20188669). While no clinical drugs targeting TagF are currently FDA-approved, experimental small molecule inhibitors and synthetic substrate analogs have demonstrated potent anti-infective potential in preclinical high-throughput screening efforts.

Other names
CDP-glycerol:poly(glycerophosphate) glycerophosphotransferaseCGPTaseMajor teichoic acid biosynthesis protein FPoly(glycerol phosphate) polymeraseTeichoic-acid synthase
02

Mechanism of action

Inhibition of teichoic acid polymerase activity to disrupt the assembly of wall teichoic acids and compromise bacterial cell wall integrity

03

Biological functions

Cell wall biosynthesisTeichoic acid polymerizationCell envelope maintenance
04

Disease associations

Infection
05

Safety considerations

Bacterial resistanceLimited cellular permeabilityEfflux-mediated resistance
06

Biomarkers

Wall teichoic acid (WTA) levelsMinimum inhibitory concentration (MIC)

Beyond the preview

Go deeper on Teichoic acid poly(glycerol phosphate) polymerase (TagF) (TagF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Teichoic acid poly(glycerol phosphate) polymerase (TagF) (TagF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call